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Summary
 
We previously isolated a partial cDNA fragment of a novel gene, 
 
Elm1
 
 (expressed in low-met-
astatic cells), that is expressed in low-metastatic but not in high-metastatic K-1735 mouse mel-
anoma cells. Here we determined the full-length cDNA structure of Elm1 and investigated the
effect of Elm1 expression on growth and metastatic potential of K-1735 cells. The 
 
Elm1
 
 gene
encodes a predicted protein of 367 amino acids showing 
 
z
 
40% amino acid identity with the
CCN (connective tissue growth factor [CTGF], Cyr61/Cef10, neuroblastoma overexpressed
gene [Nov]) family proteins, which consist of secreted cysteine-rich proteins with growth reg-
ulatory functions. Elm1 is also a cysteine-rich protein and contains a signal peptide and four
domains conserved in the CCN family proteins. Elm1 was highly conserved, expressed ubiqui-
tously in diverse organs, and mapped to mouse chromosome 15. High-metastatic K-1735 M-2
cells, which did not express Elm1, were transfected with an Elm1 expression vector, and sev-
eral stable clones with Elm1 expression were established. The in vivo growth rates of cells ex-
pressing a high level of Elm1 were remarkably slower than those of cells expressing a low level
of Elm1. Metastatic potential of transfectants was reduced in proportion to the level of Elm1
expression. Thus, 
 
Elm1
 
 is a novel gene of CCN family that can suppress the in vivo growth
and metastatic potential of K-1735 mouse melanoma cells.
 
I
 
t is now widely accepted that malignant tumors contain
heterogeneous populations of cells with regard to meta-
static potential (1). The process of cancer metastasis consists
of linked sequential steps, including invasion, detachment,
intravasation, circulation, adhesion, extravasation, and growth
in distant organs (2). Thus, high- and low-metastatic cells in a
tumor should be different each other with respect to several
biological properties, such as invasiveness, adhesiveness, mo-
tility, and proliferation potential. There is much evidence
to support the concept that each discrete step of metastasis
is regulated by transient or permanent changes at the DNA,
messenger RNA (mRNA),
 
1
 
 and/or protein levels in differ-
ent genes (3–5). By using the mRNA differential display
method, we previously identified a partial 3
 
9
 
 cDNA frag-
ment of a novel gene, 
 
Elm1
 
 (for expressed in low-meta-
static type 1 cells), that is expressed in low- but not in high-
metastatic K-1735 murine melanoma cells (6). Elm1 was
also differentially expressed between high- and low-meta-
static B16 murine melanoma cells. A partial Elm1 cDNA
fragment of 211 nucleotides showed no significant homol-
ogy to any recorded sequence in the DDBJ/GenBank/
EMBL DNA databases.
Here we determined the full-length cDNA structure of
 
1
 
Abbreviations used in this paper:
 
 bFGF, basic fibroblast growth factor; C-23,
clone 23; CCN, CTGF, Cyr61/Cef10, and Nov; CT, COOH-terminal;
CTGF, connective tissue growth factor; Elm, expressed in low-metastatic
cells; Fisp, fibroblast-inducible secreted protein; IBP, insulin-like growth fac-
tor binding protein; mRNA, messenger RNA; MSM, 
 
Mus musculus molos-
sinus
 
; Nov, neuroblastoma overexpressed gene; NovM, mouse Nov; nt,
nucleotide; TSP1, thrombospondin type 1 repeat; VWC, von Willebrand
factor type C repeat.
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the 
 
Elm1
 
 gene. The 
 
Elm1
 
 gene encoded a novel type of
CCN (connective tissue growth factor [CTGF], Cyr61/
Cef10, and neuroblastoma overexpressed gene [Nov]) fam-
ily proteins that consisted of secreted cysteine-rich mole-
cules, CTGF, Cyr61/Cef10, and Nov (7–11). CTGF and
Cyr61 were induced within minutes of stimulation by se-
rum or growth factors (10, 12) and have a growth regula-
tory function in fibroblasts or endothelial cells (13, 14).
Nov is a protooncogene isolated from myeloblastomatosis-
associated virus-induced nephroblastoma (9). Because of the
high level of sequence similarities between Elm1 and the
other members of the CCN family, it is likely that Elm1
has a function to regulate the growth of normal and/or
cancerous cells. Since Elm1 gene expression was high in
low-metastatic tumor cells and declined with increasing
metastatic potential in two rodent experimental systems,
we investigated the biological effects of the 
 
Elm1
 
 gene on
in vitro growth, in vivo growth, and metastatic potential of
K-1735 murine melanoma cells. By introduction of an
Elm1 expression vector into high-metastatic K-1735 M-2
cells that did not express endogenous Elm1, it was revealed
that expression of Elm1 can inhibit tumor growth in vivo
as well as metastasis of K-1735 melanoma cells.
 
Materials and Methods
 
Cell Lines.
 
K-1735–derived mouse melanoma cell lines were
obtained from I.J. Fidler (University of Texas, Houston, TX; ref-
erence 15). Clone 23 (designated C-23) was classified as low met-
astatic, whereas clone M-2 was high metastatic in syngeneic re-
cipients (16, 17). Serum stimulation was performed using BALB/c
3T3 cells.
 
Cell Culture and mRNA Isolation.
 
K-1735 cells and BALB/c
3T3 cells were maintained in tissue culture in the DME-10
(DME supplemented with 10% fetal calf serum, sodium bicar-
bonate solution, 
 
l
 
-glutamine, and penicillin-streptomycin). Cells
were maintained on plastic and were incubated in 5% CO
 
2
 
/95%
air at 37
 
8
 
C. Cells at 70% confluency were harvested and subjected
to mRNA extraction. mRNA was isolated using Fast Track mRNA
Isolation Kit (Invitrogen Corp., Carlsbad, CA) according to the
manufacturer’s recommendations.
 
Screening of cDNA Library.
 
To isolate full-length cDNA clones,
cDNA libraries from K-1735 C-23 (low-metastatic clone) con-
structed in lambda ZAP II (Stratagene Corp., La Jolla, CA) us-
ing cDNA Synthesis System Plus (Amersham Corp., Arlington
Heights, IL) was screened with a cloned cDNA fragment of Elm1
that was previously isolated by an mRNA differential display (6).
Isolated clones were sequenced by the A.L.F. DNA Sequencer II
with the AutoRead Sequencing Kit (Pharmacia Biotech, Piscat-
away, NJ). DNA sequences were aligned, examined for open read-
ing frames, and compared with DNA sequences in the DDBJ/
GenBank/EMBL and amino acid sequence in the SWISS-PROT
and PIR protein databases using the FASTA and BLAST pro-
grams.
 
Northern and Southern Blot Analyses.
 
3 
 
m
 
g of poly(A)
 
1
 
 RNA
were size fractionated on a denaturing formaldehyde agarose gel
(1.0%) and transferred onto Hibond-N
 
1
 
 membrane (Amersham
Corp.). Mouse multiple tissue Northern (MTN) blot, containing
2 
 
m
 
g of poly(A)
 
1
 
 RNA from a variety of tissues, and ZOO BLOT,
containing 8 
 
m
 
g of EcoRI-digested genomic DNA from various
species, were obtained from Clontech (Palo Alto, CA). Northern
blot hybridization was performed at 42
 
8
 
C for 24 h with hybrid-
ization buffer containing 50% formamide, 5
 
3
 
 NET (750 mM
NaCl, 5 mM EDTA, and 75 mM Tris-HCl), 0.5% dry milk, 0.4%
SDS, 10% dextran sulfate, and 0.2 mg/ml salmon sperm DNA.
Then the membrane was washed with 0.1
 
3
 
 SSC and 0.1% SDS
at 65
 
8
 
C for 60 min. Southern blot hybridization was performed at
37
 
8
 
C with hybridization buffer described above, and the membrane
was washed with 0.1
 
3
 
 SSC and 0.1% SDS at 55
 
8
 
C. To confirm
the amounts of mRNA loaded in each lane, the blots were hy-
bridized afterwards with a human 
 
b
 
-actin probe (Clontech). A
DNA probe for the 
 
Elm1
 
 gene corresponded to nucleotides 33–
2399 of the 
 
Elm1
 
 cDNA fragment. A DNA probe corresponding
to nucleotides 337–1119 of the 
 
Cyr61
 
 mRNA (DDBJ/Gen-
Bank/EMBL accession number: M32490) was synthesized by re-
verse transcription PCR.
 
Chromosome Mapping of the Elm1 Gene.
 
An interspecific backcross
panel formed from (DBA/2J 
 
3
 
 MSM)F1 
 
3
 
 DBA/2J (MSM, 
 
Mus
musculus molossinus
 
) was used for mapping of the 
 
Elm1
 
 gene (18).
Genotypes of Elm1 for 138 individuals in this panel were deter-
mined by RFLP observed in PCR-amplified products. A genomic
DNA fragment of 1,193 bp in the 
 
Elm1
 
 locus was amplified by
primers 5
 
9
 
-CGATATCTTTGCTGACTTGG-3
 
9
 
 (sense strand)
and 5
 
9
 
-CTGAGGCTGTAAAGTAGGTC-3
 
9
 
 (antisense strand),
corresponding to nucleotides 1223–1242 and 2396–2415, respec-
tively. The restriction enzyme 
 
Sau3AI
 
 yielded an easily distin-
guishable polymorphism between two parental strains, MSM and
DBA/2J. The data generated in this study was analyzed (Map
Manager v 2.5.6; Roswell Park Cancer Institute, NY; reference 19).
 
Serum Stimulation of BALB/c 3T3 Cells.
 
Quiescent BALB/c 3T3
cells were prepared by growth in DME-10 to confluence followed
by incubation in DME-0.5 (0.5% serum) for 2 d. For stimulation
of quiescent cells, the medium was changed to DME-20 (20%
serum).
 
Construction of Expression Vector and DNA Transfection.
 
The
pcDNA3 expression vector was purchased from Invitrogen. A
cDNA fragment of Elm1 (146–1,309 nucleotides [nt]) consisting
of 28 nts of the 5
 
9
 
-untranslated region, 1,101 nts of the coding
region, and 35 nts of the 3
 
9
 
-untranslated region was amplified us-
ing the primer set Elm1-B (146–165 nts; GTAGCTCCTGT-
GACGCTGAC) and Elm1-C (complemented 1,290–1,309 nts;
GCATGGAACTTTACCCTGAG), and ligated to the pcDNA3
vector at the BamHI site (pcDNA3-Elm1) in the direction of plus
strand. K-1735 M-2 cells were transfected with pcDNA3-Elm1
using LipofectAMINE reagent (GIBCO BRL, Gaithersburg, MD).
After 16 h, the medium was changed to DME-10. At 38 h of
transfection, G418 selection was imposed (800 
 
m
 
g/ml; Geneticin;
GIBCO BRL). G418-resistant cells were cloned by using the
penicillin cap method and maintained in the medium containing
G418. Cell clones resistant to G418 were assayed for the expres-
sion of Elm1 mRNA by Northern blotting.
 
Cell Growth and Tumorigenicity.
 
K-1735 M-2, C-23, and trans-
fectants were seeded at the density of 5 
 
3
 
 10
 
3
 
 cells/ml in a 24-well
plate. The cells were counted every day from days 1 to 6. 5-wk-old
female C3H/HeN mice were obtained from the Animal Produc-
tion of Japan Kurea Corporation (Tokyo, Japan). Tumorigenicity
was examined by injecting 10
 
6
 
 cells/0.2 ml into the subcutis of
the mice (
 
n
 
 
 
5
 
 5). The length and width of each tumor were re-
corded three times per week. The tumor volume (V) was calcu-
lated by the formula V 
 
5
 
 
 
1
 
⁄
 
2
 
 
 
3
 
 length 
 
3
 
 (width)
 
2
 
.
 
Experimental Metastasis Assay.
 
Metastatic potential of the cells
was measured by the quantitative lung colony assay as described
by Fidler et al. (20). In brief, the cells were injected into the tail
vein of 5-wk-old female C3H/HeN mice at the density of 10
 
5 
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cells/0.2 ml (
 
n
 
 
 
5
 
 5). Mice were killed when three of five mice
with K-1735 M-2 injection were dead, that is, 22 d (Table 2, ex-
periment 1) and 23 d (Table 2, experiment 2) after cell inocula-
tion. The number of lung metastatic colonies 
 
.
 
1 mm in diameter
was counted with the aid of magnifying glass.
 
Statistical Analysis.
 
The in vivo data were analyzed by the
Mann-Whitney U test.
 
DDBJ/GenBank/EMBL Accession Numbers.
 
Cyr61: M32490;
mouse Nov (NovM): X96585; fibroblast-inducible secreted pro-
tein (Fisp)12: M70642.
 
Results
 
Isolation and Characterization of the Elm1 Gene.
 
We screened
cDNA libraries from low-metastatic K-1735 C-23 cells
constructed with oligo dT and random primers using an
Elm1 cDNA fragment of 211 bp as a probe. Several clones
were obtained, sequenced, and aligned. We have assem-
bled a composite 5,020-bp transcript using the sequences of
seven independent clones (Fig. 1). We verified that the as-
sembled sequence was derived from a single gene by re-
verse transcription PCR. Searches of the DDBJ/GenBank/
EMBL nucleotide databases indicated that this sequence has
not been reported.
The composite cDNA contained an open reading frame
of 1,101 bp with a potential start codon of ATG, which was
located 10 bp downstream of an in-frame stop codon. Us-
ing this methionine as a translation start site, a peptide of
367 amino acids (40.7 kD) was predicted (Fig. 1). Sequence
homology was detected between the predicted amino acid
sequence of the Elm1 protein and those of the CCN family
proteins. The Elm1 protein showed 38.1, 44.0, and 42.6%
identity with Cyr61, Fisp12 (mouse orthologue of CTGF;
reference 10), and NovM, respectively. Elm1 has a signal
peptide that is conserved in all of the recorded CCN family
proteins. The deduced Elm1 amino acid sequence contains
a hydrophobic amino terminus with a predicted signal cleav-
age site between Ala (position 24) and Leu (position 25;
reference 21; Fig. 1). CCN family proteins are cysteine rich
(10% of all residues) and conserve the four domains: insu-
lin-like growth factor binding protein (IBP)-like domain,
von Willebrand factor type C repeat (VWC), thrombo-
spondin type 1 repeat (TSP1) domain, and COOH-termi-
nal (CT) domain (7) (Figs. 1 and 2). The deduced Elm1
amino acid sequence contains 38 of the cysteine residue
(10.4% of all residues) and showed 40–60% identity with
Figure 1. Nucleotide and predicted amino acid sequences of the Elm1
gene. Amino acids are shown in their one letter form under the corre-
sponding nucleotide sequence. An in frame 59 stop codon and the pre-
dicted termination stop codon are in bold. A potential polyadenylation
signal is indicated by bold italic letters. A signal sequence is lined under
the corresponding amino acid sequence, and underlined regions with Ro-
man numerals represent the approximate locations of the IBP-like do-
main, VWC domain, TSP1 domain, and a CT domain. The nucleotide
and amino acid numbering are indicated on the right side of the se-
quence. The nucleotide sequence data reported in this paper are available
from EMBL/GenBank/DDBJ under accession number AB004873.
Figure 2. (A) Alignment and homology of amino acid sequences cor-
responding to the IBP-like, VWC, TSP1, and CT domains of the Elm1
gene and the genes of CCN family. The predicted amino acid sequence
of the Elm1 protein is compared with those of the mouse Cyr61, NovM,
and mouse Fisp12 proteins. Positions of the identical amino acids are indi-
cated by asterisks. Consensus features in the four domains are indicated in
the consensus line (C, cysteines; t, turn-like or polar [E, D, Q, N, K, R,
T, S, P, G, A]; h, hydrophobic [I, L, V, W, Y, F, M, A, G]; a, aromatic
[Y, F, W]; reference 7). The percentage values on the right side of the
four domains of Cyr61, NovM, and Fisp12 refer to the percentage iden-
tity with the corresponding domains of Elm1. (B) Dendrogram of the
members of CCN family. The dendrogram was generated using the UP-
GMA program (GENETYX; Shibuya-ku, Tokyo, Japan; reference 31).
The horizontal distances to the subclusters correspond to the relative de-
grees of sequence identities among members. Schemata for Elm1 and
three types of mammalian CCN family proteins represented by mouse
Cyr61/chicken Cef10, chicken Nov/NovM, and human CTGF/mouse
Fisp12 were shown. 
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Cyr61, Fisp12, NovM in each of the four domains (Fig. 2).
Similarities of the amino acid sequence outside the four do-
mains were insignificant for any of the three subclasses. A
dendrogram indicates that Elm1 is not an orthologue of
other CCN family members (Fig. 2 
 
B
 
).
The 
 
Elm1
 
 gene is conserved among different species
(Fig. 3 
 
A
 
), and highly expressed in the kidney and lung,
and at lower levels in the heart, brain, spleen, liver, skeletal
muscle, and testis (Fig. 3 
 
B
 
). The 
 
Elm1
 
 locus was mapped
to chromosome 15, between the 
 
D15Mit17
 
 and 
 
D15Mit3
 
loci, which is not a site of known mouse CCN family genes
(22, 23; Fig. 4).
Quiescent BALB/c 3T3 cells were stimulated by serum,
and the expression of Elm1 and Cyr61 were examined by
Northern blot analysis (Fig. 5). Elm1 was not induced
within 30 min, but was induced after 3 h of serum stimula-
tion. Although the amount of 
 
b
 
-actin mRNA in lane 1
quantified by densitometric analysis was about half of that
in lane 3, the relative level of Elm1 expression in lane 3,
that is, the ratio of Elm1 mRNA over 
 
b
 
-actin mRNA, was
seven times higher than that in lane 1. On the other hand,
Cyr61 expression was markedly induced within 30 min
(Fig. 5).
 
Effects of Elm1 Expression on the Growth and Metastasis of
K-1735 Cells.
 
A full-length Elm1 cDNA was transfected
into K-1735 M-2 cells using the pcDNA3 vector, and sev-
eral G-418 resistant clones were tested for continued ex-
pression of Elm1 mRNA by Northern blot analysis (Fig. 6
and Table 1). M-2.Elm1.23-1 cells showed the highest
level of Elm1 mRNA expression among clones examined.
M-2.Elm1.20-3 and M-2.Elm1.6-2 cells showed a similar
level of Elm1 expression to endogenous Elm1 expression in
low-metastatic K-1735 C-23 cells. M-2.Elm1.0-1 and
M-2.Elm1.20-2 cells showed a lower level of Elm1 expression
than endogenous Elm1 expression in K-1735 C-23 cells.
M-2.Elm1.8-3 cells did not express detectable levels of Elm1,
but expressed Neo mRNA. Thus, the level of Elm1 expres-
sion in the cloned cells was in the order of M-2.Elm1.23-1 .
M-2.Elm1.20-3 . M-2.Elm1.6-2 . K-1735 C-23 . M-2.
Elm1.0-1 . M-2.Elm1.20-2 . M-2.Elm1.8-3 . K-1735
M-2 (Table 1).
We examined the in vitro growth properties of K-1735
M-2 and transfectants. Transfectants that express large
amounts of Elm1, M-2.Elm1.20-3, and M-2.Elm1.23-1
cells showed slightly increased population doubling time
and decreased saturation density compared to those of
K-1735 M-2 cells (Table 1). Morphological diversities
were not observed among the clones in association with
the level of Elm1 expression. We next injected the clones
subcutaneously into female C3H/HeN mice to evaluate
the effect of Elm1 expression on tumorigenicity. All clones
were tumorigenic, but the incidence of tumor formation
was decreased in the M-2.Elm1.23-1 cells. Moreover, in
vivo growth rates of the transfectants became slower in
proportion to the increase in the level of Elm1 expression
(Fig. 7 and Table 1).
Two independent experiments were performed to eval-
uate the metastatic ability of transfectants. The numbers of
metastatic colonies of the transfectants became smaller in
proportion to the increase in the level of Elm1 expression
Figure 3. (A) Southern blot
analysis of DNA from various
species using the Elm1 cDNA
probe. Lane 1, human; lane 2,
monkey; lane 3, rat; lane 4,
mouse; lane 5, dog; lane 6, cow;
lane 7, rabbit; lane 8, chicken;
lane 9, yeast. (B) Northern blot
analysis of the Elm1 gene in vari-
ous mouse tissues. Mouse multi-
ple tissue Northern blot (Clon-
tech) was hybridized with the
Elm1 cDNA probe (top) or a hu-
man b-actin probe (bottom). Lane
1, heart; lane 2, brain; lane 3,
spleen; lane 4, lung; lane 5, liver;
lane  6, skeletal muscle; lane 7,
kidney; lane 8, testis.
Figure 4. Linkage analysis of the Elm1 locus on mouse chromosome
15. (A) Haplotype data of 138 progenies of (DBA/2J 3 MSM)F1 3
DBA/2J for the loci flanking the Elm1 locus. The microsatellite and Elm1
loci are listed at the left. Each column represents a chromosomal haplo-
type identified in the progenies. Filled box, MSM allele; open box, DBA/2J
allele. The number of progenies for each haplotype is listed at the bottom
of each column. (B) A genetic map around the Elm1 locus constructed
from the haplotype data. Recombination frequencies expressed as genetic
distance in centiMorgan are shown on the left.
Figure 5. Expression of Elm1
and Cyr61 after serum stimulation
of BALB/c 3T3 cells. 2 mg of
poly(A)1 RNA resolved electro-
phoretically were hybridized with
the Elm1 (A) or Cyr61 (B) cDNA
probe. The membrane was rehy-
bridized with a human b-actin
probe (C). poly(A)1 RNA from
quiescent cells (lane 1), cells
stimulated with serum for 30
min (lane 2), and 3 h (lane 3)
were loaded.293 Hashimoto et al.
(Table 2). In particular, the numbers of metastatic colonies
of M-2.Elm1.23-1 cells were significantly lower than those
of K-1735 M-2 cells in both experiments (Table 2). The
numbers of metastatic colonies of M-2.Elm1.20-3 cells
were significantly lower than those of K-1735 M-2 cells in
experiment 1. Low-metastatic C-23 cells did not produce
lung colonies. Metastatic colonies of M-2, M-2.Elm1.8-3,
M-2.Elm1.20-3, and M-2.Elm1.23-1 cells in experiment 1
are shown in Fig. 8.
Discussion
We determined the full-length cDNA structure of the
Elm1 gene that was expressed in low-metastatic but not in
high-metastatic murine melanoma cells. Elm1 is a novel
mouse gene and showed a sequence similarity to the CCN
family. CCN family members have been defined as pro-
teins with a mosaic structure because they all contain sev-
eral motifs shared by various functionally unrelated proteins
(7). The Elm1 gene product highly conserved these motifs,
including the IBP-like, VWC, TSP1, and CT domains
(Fig. 2). Identity of amino acid sequence between the de-
duced Elm1 and the other CCN family proteins was
z40%, and a dendrogram indicated that no recorded CCN
family members would be an orthologue of Elm1. These
results suggest that the Elm1 gene belongs to a new subclass
of the CCN family.
CCN family members are considered to function in a
wide variety of biological processes, such as tissue regenera-
tion, tumor formation, and embryonic development, as sig-
nal molecules to the extracellular matrix (7, 13, 14). CTGF
is induced by TGF-b and mediates mitogenic effects of
TGF-b on fibroblasts (13). Cyr61 is transcriptionally acti-
vated by serum growth factors in fibroblasts, secreted to the
extracellular matrix, and enhances the mitogenic effect of
basic fibroblast growth factor (bFGF) on fibroblasts and en-
dothelial cells (10, 14). Nov was isolated from an integra-
tion site of myeloblastomatosis-associated virus (MAV) and
overexpressed in MAV-induced nephroblastoma (9). CTGF
and Cyr61 are classified as immediate early genes involved
in the control of cell proliferation because they are induced
within 30 min after serum stimulation. (10, 12). In contrast
to CTGF and Cyr61, Nov is downregulated in proliferat-
ing fibroblasts (24). Elm1 was induced by serum, but not
induced within 30 min. Thus, Elm1 would play a different
role from the other CCN family members in proliferating
fibroblasts. CTGF is a mitogenic growth factor (8). Cyr61
itself does not act as a mitogen, but has the ability to en-
hance the effect of bFGF on DNA synthesis (14). Nov pro-
tein has a growth suppressor activity in fibroblasts (9). To
examine whether Elm1 has such a growth regulatory func-
tion, we performed thymidine incorporation assay using
sample mediums of Elm1-transfected K-1735 M-2 cells.
However, we could not detect mitogenic activity of Elm1
by itself or the ability of Elm1 to enhance the effect of
bFGF on NIH3T3 cells (data not shown). Thus, it is un-
Figure 6. Northern blot anal-
ysis of Elm1 transfectants using the
Elm1 (A), Neo (B), and b-actin
(C) probes. The size of exogenous
and endogenous Elm1 transcripts
are 1.5 and 5.0 kb, respectively.
Lane 1, K-1735 C-23; lane 2,
K-1735 M-2; lane 3, M-2.Elm1.
23-1; lane 4, M-2.Elm1.20-3; lane
5, M-2.Elm1.0-1; lane 6, M-2.
Elm1.6-2; lane 7, M-2. Elm1.
20-2; lane 8, M-2.Elm1.8-3.
Table 1. In Vitro Growth Properties and Tumorigenicity of K-1735 M-2 Cells Transfected with the Elm1 Gene
Cell line
Expression
of Elm1*
Population
doubling time‡
Saturation density in 
media with 10% FCS
Tumorigenicity§
Expt. 1 Expt. 2
h
K-1735 M-2 0.0 13.8 1.1 3 106 5/5 (21) 5/5 (22)
M-2.Elm1.8-3 0.0 13.1 0.9 3 106 5/5 (20) 5/5 (19)
M-2.Elm1.20-2 0.2 13.5 0.8 3 106 4/5 (27) 5/5 (21)
M-2.Elm1.0-1 0.6 15.0 0.9 3 106 3/5 (32) 5/5 (24)
M-2.Elm1.6-2 1.4 13.3 1.1 3 106 5/5 (37) 5/5 (28)
M-2.Elm1.20-3 1.6 16.1 0.5 3 106 4/5 (.60) 5/5 (.60)
M-2.Elm1.23-1 6.3 16.0 0.3 3 106 2/5 (46) 1/5 (.60)
K-1735 C-23 1.0 13.5 0.9 3 106 0/5 1/5 (49)
*The amount of Elm1 and b-actin mRNA was quantified by Northern blot densitometric analysis of the autoradiogram. RNA loading levels were
standardized with respect to the amount of b-actin mRNA. Levels of standardized Elm1 mRNA were expressed relative to the standardized level in
K-1735 C-23 cells.
‡Growth rate was estimated from the logarithmic phase of the growth curve.
§Observed for up to 60 d after inoculation of 106 viable cells into 5-wk-old syngeneic mice. Tumorigenicity is expressed by the number of mice
with tumors per the number of mice injected. Average days of tumors that reached 1 cm3 in each group are shown in parentheses.294 Elm1 Suppresses Tumor Growth and Metastasis of Mouse Melanoma Cells
likely that Elm1 itself has growth regulatory function on
the NIH3T3 fibroblast. However, it is possible that Elm1
might enhance the mitogenic effect of growth factors other
than bFGF.
We found that Elm1 gene transaction resulted in an in-
hibition of in vivo growth and metastasis formation. Ex-
pression of Elm1 had little suppressive effect on in vitro
growth, but a marked suppressive effect on in vivo growth.
Suppressive effect of Elm1 on metastatic potential was asso-
ciated with suppressive effect of Elm1 on in vivo growth.
In M-2.Elm1.23-1 and M-2.Elm1.20-3 cells that express
high levels of Elm1, a reduction in the incidence of subcu-
taneous tumor formation as well as metastatic formation was
observed. The reason why the cells failed to form tumors is
presently unknown, but may result from alterations in tu-
mor cell–host interactions, such as angiogenesis and/or re-
sponses to stimulatory and suppressive cytokines (25). TSP1
inhibits angiogenesis and modulates endothelial cell adhe-
sion, motility, and growth. The antiproliferative activity of
TSP1 is mimicked by a synthetic peptide derived from the
type 1 repeats of TSP1 that antagonizes fibroblast growth fac-
tor and induces programmed cell death in bovine aortic en-
dothelial cells (26). Thus, it is possible that an inhibition of
angiogenesis by the TSP1 domain of Elm1 leads to the sup-
pression of in vivo growth. Further studies are now in pro-
gress on this subject.
Elm1 was isolated as a gene differentially expressed be-
tween high- and low-metastatic K-1735 mouse melanoma
cells. In K-1735 systems, actin organization, cell adhesion,
motility, and a growth rate at a subcutaneous site have been
shown to be different between high- and low-metastastic
cells (27–29). Elm1 could be a gene that is involved in the
growth of K-1735 cells in vivo. It is noted that the Elm1
gene is one of several genes involved in the regulation of
metastatic potential in K-1735 cells since it was previously
shown that expression of the inducible nitric oxide syn-
thase and nm23 genes suppresses tumorigenicity and me-
tastasis of K-1735 cells (25, 30). These sets of genes would
cooperatively affect the metastatic potential of K-1735
cells. A more detailed characterization of the Elm1 gene
should allow a critical analysis of the molecular mechanism
of metastasis in K-1735 cells.
Figure 7. In vivo growth of K-1735 M-2 cells transfected with the
Elm1 gene. (A) Experiment 1; (B) experiment 2. 106 cells were inoculated
subcutaneously into syngeneic mice and tumor growth was monitored three
times per week. Average volume in mice with tumors and SD of values
(bars) are shown.
Table 2. Experimental Lung Metastasis of K-1735 M-2 Cells 
Transfected with the Elm1 Gene
Cell line*
Lung metastasis
Incidence Median Range
Expt. 1
K-1735 M-2 5/5 126 36–162
M-2.Elm1.8-3 5/5 149 143–176
M-2.Elm1.20-2 4/5 115 0–148
M-2.Elm1.0-1 5/5 71 27–127
M-2.Elm1.6-2 3/5 28 0–136
M-2.Elm1.20-3 5/5 3‡ 2–7
M-2.Elm1.23-1 0/5 0‡ 0
K-1735 C-23 0/5 0‡ 0
Expt. 2
K-1735 M-2 5/5 94 10–153
M-2.Elm1.8-3 5/5 123 34–156
M-2.Elm1.20-2 4/5 66 0–142
M-2.Elm1.0-1 3/5 10 0–100
M-2.Elm1.6-2 5/5 5 3–116
M-2.Elm1.20-3 3/5 8 0–11
M-2.Elm1.23-1 3/5 1‡ 0–7
K-1735 C-23 0/5 0‡ 0
*Syngeneic mice were injected intravenously with 105 viable cells and
killed after 22 (experiment 1) and 23 d (experiment 2) of injection. The
number of lung colonies was determined using a magnifying glass.
‡The number of lung colonies of these cells were significantly different
from that of K-1735 M-2 cells (Mann-Whitney U test, P ,0.01).295 Hashimoto et al.
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